study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clini...
Project: SPIOMET4HEALTH
Updated at: 11-05-2024
Project: SPIOMET4HEALTH
Updated at: 11-05-2024
Project: SPIOMET4HEALTH
Updated at: 11-05-2024
Project: SPIOMET4HEALTH
Updated at: 14-04-2024
Project: SPIOMET4HEALTH
Updated at: 14-04-2024
Project: SPIOMET4HEALTH
Updated at: 14-04-2024
Project: SPIOMET4HEALTH
Updated at: 01-01-2024